These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 7333970)

  • 1. 9-epi-leucomycin A5. Synthesis and antimicrobial activity.
    Sakakibara H; Fujiwara T; Aizawa M; Omura S
    J Antibiot (Tokyo); 1981 Dec; 34(12):1577-80. PubMed ID: 7333970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acyl derivatives of 16-membered macrolides. I. Synthesis and biological properties of 3"-O-propionylleucomycin A5 (TMS-19-Q).
    Sakakibara H; Okekawa O; Fujiwara T; Otani M; Omura S
    J Antibiot (Tokyo); 1981 Aug; 34(8):1001-10. PubMed ID: 7319915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and biological evaluation of novel leucomycin analogues modified at the C-3 position. I. Epimerization and methylation of the 3-hydroxyl group.
    Furuuchi T; Kurihara K; Yoshida T; Ajito K
    J Antibiot (Tokyo); 2003 Apr; 56(4):399-414. PubMed ID: 12817814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acyl derivatives of 16-membered macrolides. II. Antibacterial activities and serum levels of 3"-O-acyl derivatives of leucomycin.
    Sakakibara H; Okekawa O; Fujiwara T; Aizawa M; Omura S
    J Antibiot (Tokyo); 1981 Aug; 34(8):1011-8. PubMed ID: 7319916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-activity relationships among the O-acyl derivatives of leucomycin. Correlation of minimal inhibitory concentrations with binding to Escherichia coli ribosomes.
    Omura S; Nakagawa A; Sakakibara H; Okekawa O; Brandsch R
    J Med Chem; 1977 May; 20(5):732-6. PubMed ID: 404425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel dimeric derivatives of leucomycins and tylosin, sixteen-membered macrolides.
    Omura S; Miyano K; Matsubara H; Nakagawa A
    J Med Chem; 1982 Mar; 25(3):271-5. PubMed ID: 7040661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative structure-activity relationships of O-acyl derivatives of leucomycin for antimicrobial and ribosome-binding activities.
    Tanaka H; Moriguchi I; Hirono S; Omura S
    Chem Pharm Bull (Tokyo); 1985 Jul; 33(7):2803-8. PubMed ID: 4085039
    [No Abstract]   [Full Text] [Related]  

  • 8. Chemical modification of spiramycins. VI. Synthesis and antibacterial activities of 3,3''-di-O-acyl-4''-O-sulfonyl and 3,3''-di-O-acyl-4''-O-alkyl derivatives of spiramycin I.
    Sano M; Sunazuka T; Tanaka H; Yamashita K; Okachi R; Omura S
    J Antibiot (Tokyo); 1985 Oct; 38(10):1350-8. PubMed ID: 4066488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microbial transformation of leucomycin A5.
    Singh K; Rakhit S
    J Antibiot (Tokyo); 1979 Jan; 32(1):78-80. PubMed ID: 761994
    [No Abstract]   [Full Text] [Related]  

  • 10. Chemical modification of spiramycins. II. Synthesis and antimicrobial activity of 4'-deoxy derivatives of neospiramycin I and their 12-(Z)-isomers.
    Sano H; Inoue M; Omura S
    J Antibiot (Tokyo); 1984 Jul; 37(7):738-49. PubMed ID: 6469868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and structure-activity studies of new 4''-O-acyltylosin derivatives of therapeutic interest.
    Yoshioka T; Kiyoshima K; Maeda M; Sakamoto M; Ishikura T; Fukagawa Y; Sawa T; Hamada M; Naganawa H; Takeuchi T
    J Antibiot (Tokyo); 1988 Nov; 41(11):1617-28. PubMed ID: 3198495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Syntheses and antimicrobial activities of 9-O-acyl derivatives of tylosin and demycarosyltylosin.
    Tsuzuki K; Matsubara H; Nakagawa A; Omura S
    J Antibiot (Tokyo); 1986 Dec; 39(12):1784-7. PubMed ID: 3818453
    [No Abstract]   [Full Text] [Related]  

  • 13. Electronic and lipophilic interactions of macrolides (leucomycin derivatives) with ribosomal receptor sites.
    Mager PP
    Acta Histochem; 1980; 66(1):40-3. PubMed ID: 6776777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modifications of a macrolide antibiotic midecamycin. II. Reaction of midecamycin and 9-acetylmidecamycin with dimethylsulfoxide and acetic anhydride.
    Inouye S; Omoto S; Iwamatsu K; Niida T
    J Antibiot (Tokyo); 1980 Jan; 33(1):61-71. PubMed ID: 7372551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 19-Deformyl-4'-deoxydesmycosin (TMC-016): synthesis and biological properties of a unique 16-membered macrolide antibiotic.
    Fujiwara T; Watanabe H; Kogami Y; Shiritani Y; Sakakibara H
    J Antibiot (Tokyo); 1989 Jun; 42(6):903-12. PubMed ID: 2500413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modification of the macrolide antibiotic midecamycin. III. Formation of neoisomidecamycin.
    Omoto S; Ogino H; Iwamatsu K; Inouye S
    J Antibiot (Tokyo); 1982 Nov; 35(11):1521-6. PubMed ID: 7161192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Spiramycin derivatives. 1].
    Takahira H
    Jpn J Antibiot; 1970 Aug; 23(4):424-8. PubMed ID: 5312794
    [No Abstract]   [Full Text] [Related]  

  • 18. Inhibition of the biosynthesis of leucomycin, a macrolide antibiotic, by cerulenin.
    Takeshima H; Kitao C; Omura S
    J Biochem; 1977 Apr; 81(4):1127-32. PubMed ID: 881413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-Substituted derivatives of 23-amino-4',23-dideoxymycaminosyl tylonolide. Synthesis and antibacterial activity.
    Sakamoto S; Tsuchiya T; Tanaka A; Umezawa S; Hamada M; Umezawa H
    J Antibiot (Tokyo); 1985 Apr; 38(4):477-84. PubMed ID: 4008340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemical modification of spiramycins. IV. Synthesis and in vitro and in vivo activities of 3'',4''-diacylates and 3,3'',4''-triacylates of spriamycin I.
    Sano H; Sunazuka T; Tanaka H; Yamashita K; Okachi R; Omura S
    J Antibiot (Tokyo); 1984 Jul; 37(7):760-72. PubMed ID: 6469870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.